Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
NCT06032078 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2023-09-11
Summary
This prospective study aims to evaluate the responsiveness of the validated investigator global assessment (IGA) and composite area index score for keratosis pilaris by data collection through treatment and scoring sessions held at a private practice and relevant statistical analysis.
Conditions
- Keratosis Pilaris
Interventions
- DEVICE
-
Cutera laser machine
1064nm Nd: YAG laser
Sponsors & Collaborators
-
The University of New South Wales
collaborator OTHER -
Premier Specialists, Australia
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-26
- Primary Completion
- 2023-12-29
- Completion
- 2023-12-29
Countries
- Australia
Study Locations
More Related Trials
-
Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis
NCT02670655 ·Status: COMPLETED ·Phase: PHASE1
-
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
NCT03846531 ·Status: COMPLETED ·Phase: NA
-
Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris
NCT04797663 ·Status: COMPLETED ·Phase: PHASE4
-
Dermatosis Papulosa Nigra
NCT00710203 ·Status: COMPLETED ·Phase: NA
-
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
NCT04249115 ·Status: TERMINATED ·Phase: NA
-
Microwave Treatment for Actinic Keratosis
NCT05636800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NCT02559934 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of an E-learning Program on Recognition of Actinic Keratosis
NCT05987553 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of IDEA-070 on Pain and Inflammation Induced by PDT
NCT00269074 ·Status: COMPLETED ·Phase: PHASE2
-
High- and Low-risk Actinic Keratosis Referrals to Secondary Care
NCT05976061 ·Status: ACTIVE_NOT_RECRUITING
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris
NCT07078461 ·Status: RECRUITING ·Phase: NA
-
NdYag Laser for Acne Keloidalis Nuchae
NCT00757315 ·Status: UNKNOWN ·Phase: NA
-
Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis
NCT03325803 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial
NCT04429607 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
NCT00367328 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
NCT03731988 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Investigate GZ21T in Healthy Volunteers
NCT06888362 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
NCT02029066 ·Status: COMPLETED ·Phase: PHASE1
-
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
NCT00756288 ·Status: WITHDRAWN ·Phase: NA
-
Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema
NCT05622253 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
NCT01493921 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
NCT00952783 ·Status: COMPLETED
-
Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
NCT01703078 ·Status: COMPLETED ·Phase: PHASE1
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3